These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38856761)

  • 1. Chemotherapy-induced neuropathy and pain in pediatric oncology patients: impact of combination therapies.
    Soriano D; Santos Chocler G; Varela MA; Coronel MF
    Eur J Pediatr; 2024 Sep; 183(9):3749-3756. PubMed ID: 38856761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy.
    Molassiotis A; Cheng HL; Lopez V; Au JSK; Chan A; Bandla A; Leung KT; Li YC; Wong KH; Suen LKP; Chan CW; Yorke J; Farrell C; Sundar R
    BMC Cancer; 2019 Feb; 19(1):132. PubMed ID: 30736741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
    Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
    Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring clinical markers of Axon degeneration processes in Chemotherapy-induced peripheral neuropathy among young adults receiving vincristine or paclitaxel.
    Knoerl R; Mazzola E; Pazyra-Murphy M; Ryback B; Frazier AL; Freeman RL; Hammer M; LaCasce A; Ligibel J; Luskin MR; Berry DL; Segal RA
    BMC Neurol; 2024 Sep; 24(1):366. PubMed ID: 39342135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
    JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
    Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
    Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort.
    Shah A; Hoffman EM; Mauermann ML; Loprinzi CL; Windebank AJ; Klein CJ; Staff NP
    J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):636-641. PubMed ID: 29439162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.
    Weintraub M; Adde MA; Venzon DJ; Shad AT; Horak ID; Neely JE; Seibel NL; Gootenberg J; Arndt C; Nieder ML; Magrath IT
    J Clin Oncol; 1996 Mar; 14(3):935-40. PubMed ID: 8622042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia Is a Novel Predictive Factor for the Onset of Severe Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Patients Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone Therapy.
    Saito T; Okamura A; Inoue J; Makiura D; Doi H; Yakushijin K; Matsuoka H; Sakai Y; Ono R
    Oncol Res; 2019 Mar; 27(4):469-474. PubMed ID: 30126466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastroesophageal Cancer.
    van Velzen MJM; Pape M; Sprangers MAG; van Kleef JJ; Mostert B; Beerepoot LV; Slingerland M; Gootjes EC; Hoekstra R; van de Poll-Franse LV; Haj Mohammad N; van Laarhoven HWM
    J Natl Compr Canc Netw; 2024 Jul; 22(7):455-461. PubMed ID: 38977016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
    Albany C; Dockter T; Wolfe E; Le-Rademacher J; Wagner-Johnston N; Einhorn L; Lafky JM; Smith E; Pachman D; Staff N; Ma C; Loprinzi CL; Costello BA
    Support Care Cancer; 2021 Feb; 29(2):833-840. PubMed ID: 32500206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
    Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS
    Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy.
    Hung HW; Liu CY; Chen HF; Chang CC; Chen SC
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34073174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study.
    Parsons SK; Rodday AM; Pei Q; Keller FG; Wu Y; Henderson TO; Cella D; Kelly KM; Castellino SM
    J Patient Rep Outcomes; 2023 Nov; 7(1):113. PubMed ID: 37947987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer.
    Saint K; Nemirovsky D; Lessing A; Chen Y; Yang M; Underwood WP; Galantino ML; Jones LW; Bao T
    Breast Cancer Res Treat; 2024 Aug; 206(3):667-675. PubMed ID: 38713289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying trajectories and predictors of chemotherapy-induced peripheral neuropathy symptoms, physical functioning, and falls across treatment and recovery in adults treated with neurotoxic chemotherapy: the PATTERN observational study protocol (NCT05790538).
    Winters-Stone KM; Krasnow SM; Horak FB; Mancini M; Cameron MH; Dieckmann NF; Stoyles SA; Roeland EJ
    BMC Cancer; 2023 Nov; 23(1):1087. PubMed ID: 37946117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort.
    Sreeram K; Seaton R; Greenwald MK; Kamgar M; Assad H; Baird T; Schwartz AG; Ruterbusch J; Simon MS
    Cancer Causes Control; 2023 May; 34(5):459-468. PubMed ID: 36934365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing Clinical Screening for Chemotherapy-Induced Peripheral Neuropathy.
    McCrary JM; Goldstein D; Trinh T; Timmins HC; Li T; Friedlander M; Bosco A; Harrison M; Maier N; O'Neill S; Park SB
    J Pain Symptom Manage; 2019 Dec; 58(6):1023-1032. PubMed ID: 31374367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia.
    Rodwin RL; Kairalla JA; Hibbitts E; Devidas M; Whitley MK; Mohrmann CE; Schore RJ; Raetz E; Winick NJ; Hunger SP; Loh ML; Hockenberry MJ; Angiolillo AL; Ness KK; Kadan-Lottick NS
    J Natl Cancer Inst; 2022 Aug; 114(8):1167-1175. PubMed ID: 35552709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.